Trial intelligence / Profile preview

Dexamethasone Dose Comparison in ITP

NCT02153060Phase 2Completed

Sponsor
Shandong University
Start
May 2014
Primary completion
Jan 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of dexamethasone in immune thrombocytopenia (ITP), sponsored by Shandong University. Started May 2014; status: completed.

02

Drugs

dexamethasone
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on NCT02153060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02153060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call